Vanda reports Q2 2026 results, reaffirms guidance and three Phase III readouts by year-endAug 5Quarterly updateiloperidonemilsaperidone
Vanda's HETLIOZ gets manufacturing supplement approval from FDAJul 27Regulatory decisiontasimelteonVanda Pharmaceuticals Inc.
Sign inSign in